Related Experiment Videos
[Microglia--new target cells for neurological therapy]
1Institutionen för neurovetenskap, Uppsala biomedicinska centrum, Uppsala universitet. Hakan.Aldskogius@neuro.uu.se
Abstract:
Disturbances in the normal homeostasis of the central nervous system induce a localized activation of microglia. This activation serves to isolate pathological processes from surrounding, intact nervous tissue. Concomitantly, healthy or minimally damaged nerve cells nearby may be negatively influenced by potent molecules released by activated microglia. This situation appears to exist e.g. in ischemia, multiple sclerosis and Alzheimer's disease. Pharmacologic regulation of microglial activity is therefore a rational approach to treatment of many central nervous system disorders.
Insights
Microglia activation in the central nervous system can harm healthy neurons. Regulating microglial activity offers a promising therapeutic strategy for neurological disorders like Alzheimer's disease.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Context:
- Central nervous system (CNS) homeostasis is disrupted by pathological processes.
- Microglia, the resident immune cells of the CNS, become activated in response to disturbances.
- This microglial activation can lead to the release of molecules that negatively affect nearby healthy neurons.
Purpose:
- To explore the dual role of microglial activation in CNS disorders.
- To highlight the potential of modulating microglial activity for therapeutic benefit.
Summary:
- Microglial activation, a localized response to CNS disturbances, aims to contain pathology.
- However, activated microglia also release factors that can damage adjacent healthy neural tissue.
- This phenomenon is observed in conditions such as ischemia, multiple sclerosis, and Alzheimer's disease.
Impact:
- Understanding microglial behavior is crucial for developing treatments for neurodegenerative and neurological diseases.
- Targeting microglial activity presents a potential therapeutic avenue for a range of CNS disorders.
- Pharmacological interventions aimed at regulating microglial function could offer neuroprotective benefits.